CA19-9
| Names | |
|---|---|
| Systematic IUPAC name (12S,14S,15R,16R,32R,33R,34S,35S,36R,52R,53S,54R,55R,56Ξ,72S,73S,74R,75S,76S)-15,55-Diacetamido-14,33,35,56,73,74,75-heptahydroxy-36,52-bis(hydroxymethyl)-76-methyl-16-[(1R,2R)-1,2,3-trihydroxypropyl]-2,4,6-trioxa-1,7(2),3(4,2),5(4,3)-tetraoxanaheptaphane-12-carboxylic acid | |
| Other names sialyl LeA, SLeA, cancer antigen 19-9, CA19-9 | |
| Identifiers | |
| 3D model (JSmol) | |
| ChEBI | |
| ChemSpider | |
| MeSH | sialyl+Lewis+A | 
| PubChem CID | |
| UNII | |
| 
 | |
| Properties | |
| C31H52N2O23 | |
| Molar mass | 820.748 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Carbohydrate antigen 19-9 (CA19-9), also known as sialyl-LewisA, is a tetrasaccharide which is usually attached to O-glycans on the surface of cells. It is known to play a role in cell-to-cell recognition processes. It is also a tumor marker used primarily in the management of pancreatic cancer.